The TERT rs2736100 Polymorphism and Cancer Risk: A Meta-analysis Based on 25 Case-Control Studies

BMC Cancer

Table 4 Stratified analyses of the TERT rs2736100 polymorphism on adenocarcinoma

Variables	GG versus TT		GT versus TT		Dominant model		Recessive model		Additive model
	OR(95%CI)	P ^a	OR(95%CI)	P ^a	OR(95%CI)	P ^a	OR(95%CI)	P ^a	OR(95%CI)	P ^a
Total	1.85(1.72-1.98)	0.117	1.44(1.31-1.59)^b	0.037	1.56(1.42-1.71)^b	0.030	1.50(1.41-1.60)	0.447	1.36(1.31-1.41)	0.169
Source of control
Population based	2.36(1.96-2.83)	0.515	1.71(1.48-1.98)	0.052	1.86(1.62-2.13)	0.078	1.64(1.41-1.92)	0.648	1.52(1.39-1.65)	0.497
Hospital based	1.74(1.59-1.90)	0.532	1.34(1.24-1.44)	0.954	1.44(1.34-1.54)	0.875	1.45(1.34-1.57)	0.454	1.32(1.26-1.38)	0.610

^a P value of Q-test for heterogeneity test
^bRandom-effects model was used when P value for heterogeneity test <0.05; otherwise, fix-effects model was used

ISSN: 1471-2407